RE:RE:RE:Options not exercised yetEven if I were in Montreal, my French is nowhere near good enough to pick up any scuttlebutt haha. I have visited the city but that is the extent of my Montreal inside scoop.
SPCEO1 wrote: Thanks for that. That is a long blackout period for results! I still suspect something is up but I couldn't tell you if it is good or bad, but my guess is it leans good. I mean, the situation calls for action, right? So, something is likely to be acted upon with a NASH partnership being the most likely culprit. I could imagine a lot of other possibilities as well. THTX's assets are their legacy drug business, a wounded but still intriguing cancer drug prospect, a ready to go late stage NASH trial in an now hot again NASH market,a partnership with Taimed who has another, much bigger HIV drug in testing, a flyer on cognition in Egrifta and a big tax loss carryforward position. They should be able to make something positive out of all that. Aren't you based in Montreal? Have you heard any scuttlebutt about cost cutting at THTX?
SABBOBCAT wrote: Sorry SPCEO, this is false. Insiders are in blackout from mid Nov until the annual results are released. During this time they are unable to excerceise the options. In reaching out to IR, the expiry has been extended to 10 days after the blackout period ends.
SPCEO1 wrote: Since those options have not yet been exercised, it appears THTX is involved in some matter that is important enough to prevent insiders from trading. The most obvious choice is a NASH partnership but there are certainly other possibilities. I am also surprised that we have heard nothing about cost cutting going on at THTX. Has anyone of you in Montreal heard anything about cost cutting? The fact that we have not heard about significant lay-offs might reflect the implications for whatever is going on that is keeping the two executives from exercising their very cheap options. If there is some good news on the horizon, perhaps the impetus to reduce costs immediately has been lowered.